Viemed Healthcare: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits

Item 2.02. Results of Operations and Financial Condition.On November 4, 2026, Viemed Healthcare, Inc. (the "Company") issued a press release announcing its financial results for the three and nine months ended September 30, 2026. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.In addition, the Company issued a Financial Supplement with respect to its financial results for the three and nine months ended September 30, 2026. The Financial Supplement is attached hereto as Exhibit 99.2 and is incorporated herein by reference.In accordance with General Instruction B.2 of Form 8-K, the foregoing information, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information and Exhibits 99.1 and 99.2 be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.Item 7.01. Regulation FD DisclosureThe Company expects to use the presentation attached to this Current Report on Form 8-K as Exhibit 99.3 (the “Investor Deck Presentation”) and incorporated herein by reference, in whole or in part, and possibly with modifications, in connection with presentations to investors, analysts and others. The Investor Deck Presentation is also available on the Company’s website, https://www.viemed.com/investors. The information contained in the Investor Deck Presentation is summary information that is intended to be considered in the context of the Company's Securities and Exchange Commission (“SEC”) filings and other public announcements that the Company may make, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in the Investor Deck Presentation, except as required by law although it may do so from time to time as its management believes is warranted. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosure.The information presented in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.3 shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered “filed” under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.Item 9.01. Financial Statements and Exhibits(d)Exhibits Exhibit NumberDescription99.1 Press Release dated November 4, 2026.99.2 Financial Supplement dated November 4, 2026.99.3 Viemed Investor Deck Presentation November 2026.104 Cover Page Interactive Data File (embedded within the Inline XBRL document)SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 4, 2026 VIEMED HEALTHCARE, INC.By:/s/ Trae FitzgeraldTrae FitzgeraldChief Financial Officer

Viemed Healthcare: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits

Інші новини компанії